Nauset Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Nauset Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$27K	Buy	+374	New	+$25.1K	0.02%	161

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Nauset Wealth Management's BMY Position: Q1 2022 in Review

Nauset Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2022: 374 shares worth $27K. The stake represents 0.02% of the portfolio and ranks #161 among its holdings.

2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Nauset Wealth Management held 374 shares of Bristol-Myers Squibb worth $27K as of Q1 2022.
Bristol-Myers Squibb was a new Nauset Wealth Management position in Q1 2022.
Bristol-Myers Squibb made up 0.02% of Nauset Wealth Management's portfolio in Q1 2022, its #161 holding.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Nauset Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.